The Food and Drug Administration has approved the world’s first medicine based on CRISPR gene-editing technology, a ...

Many high risk, high reward medical therapies that use cutting edge science are proving themselves in clinical trials. But are health services ready to pay for them—and how? Marianne Guenot reports On ...

Following a breakthrough 'cure' for sickle cell disease being approved on the NHS, the Mirror sat down with four British ...

While somatic gene editing, which is currently used to treat conditions like sickle-cell anemia, only affects the diseased individual, germline editing alters an entire lineage. It’s illegal in the ...

While de-extinction projects capture headlines with dreams of resurrecting mammoths, the same technologies at play — especially CRISPR — are quietly transforming something even more profound: human ...

Sickle cell disease, characterised by the abnormal sickle shape of red blood cells instead of the typical round form, is the UK's most rapidly expanding genetic disorder. This deformation causes ...

When even one tiny section of a person’s genetic code becomes mutated or modified, cells can begin to act out of ...

Groundbreaking gene-editing treatment exa-cel is now available for NHS patients with sickle cell disease, offering a ...

Gene editing technologies have cemented their place as a valued method in the biological toolkit used by researchers around the globe.

ToolGen files patent infringement lawsuit against Vertex Pharma in UK for genome editing therapy CASGEVY: Seoul, South Korea Tuesday, April 22, 2025, 15:00 Hrs [IST] ToolGen, Inc.